Terminal differentiation of human breast cancer through PPAR gamma.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerThe Role of PPARs in CancerPeroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiationPPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesisExposure to phthalates and breast cancer risk in northern MexicoTReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesteroneCyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivationRole of Peroxisome Proliferator-Activated Receptors in Inflammation ControlAdvances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and diseaseA retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor liRole of nuclear receptors in breast cancer stem cellsLipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancerPPAR-γ -- a possible drug target for complicated pregnanciesHyperglycemia as a risk factor for cancer progressionPPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsActivation of PPARalpha and PPARgamma by environmental phthalate monoestersClinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumoursActivation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cellsThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesEffects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in miceOmega-3 Fatty Acids and PPARgamma in CancerInduction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcomaRole of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cellsPeroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinomaLigands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX miceAPC-dependent suppression of colon carcinogenesis by PPARgammaAnticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells: involvement of PPARγHic-5 regulates an epithelial program mediated by PPARgammaCyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdeltaBGRMI: A method for inferring gene regulatory networks from time-course gene expression data and its application in breast cancer researchInferring tumour purity and stromal and immune cell admixture from expression dataPharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcomaPPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaCOX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situRosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imagingTroglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cellsTherapeutic Implications of PPARgamma in Human Osteosarcoma.
P2860
Q21328702-06615796-E095-49D5-83CC-D08E700B5478Q21342955-842540EF-0A1B-42F6-AA87-B8023209F707Q24553023-81BBD687-EF53-4332-B2A5-AB97D8D4D48BQ24553314-DC43D34B-B55B-4FF6-916E-9B8BD208DDF9Q24594495-559D09BC-E328-4F4C-8ADB-7159ECD0BD82Q24671974-60591C44-52B4-48E4-BE79-1E207E14FB7DQ24684054-3AA50A96-7DEA-490C-8E23-098B0E7037EBQ24796541-5C4774EC-5E89-43D2-9A11-0115AA7D4F7CQ24803926-F64D30F6-C04D-4B89-9696-3FCBD407D48BQ24806395-22437232-08E5-4478-B1B3-7681F89509F5Q26750359-5397C5B0-B814-4EA7-8F12-8F3E38714A06Q26764743-7E0F773B-49B2-4DB0-A4BB-B2B5E5F5309CQ26863678-600D8064-6CD1-4E11-AE42-5A81AA6F32F6Q27687614-247CBDC3-92AE-45F3-B247-17BC0BB31AD8Q28066756-1DB62A2D-F2E7-47C1-A43E-5781CB0EF6DCQ28179002-1A38DBBA-E94A-4638-9921-D2ABF44912E3Q28209267-B6ADF0C8-C744-4F4B-9267-093CB12F4B7CQ28214426-0F5C9219-50F8-440B-BFF3-F95FF71BA738Q28238709-457351AB-9C8D-4851-8B73-273BBDDF42CBQ28263562-968F5847-33B8-4C73-8D35-2437E2E175B1Q28292907-F2EABF07-E682-41FA-8DBA-9CC97A009A1AQ28343226-BB19EEDD-998D-43A7-89A8-3912E69180FEQ28345289-BCA965D9-BDBE-45F2-9FCA-7ABF15511A71Q28366616-1465A193-FF9D-4D90-A588-EF94B556AAF4Q28368272-41272BB9-F9C2-43E8-92D0-3A5BED93A9DBQ28506424-60D87168-110B-4FA9-9192-ED94E54CCC15Q28541836-694ED316-27BE-49A9-9A2A-83E4798779D1Q28586821-224F3C87-EB1C-4BC9-9346-29C24F42D3ADQ28587698-3EE908D0-8138-4660-B096-A1A039F3330BQ28595423-8A0919F0-FBEE-4925-96BA-A6AE4ED90786Q30674996-2311E3A1-F14E-4B52-BC6C-35025B1165DDQ30977623-864AC5C1-36DD-4A19-9E10-23E391397DE8Q33183474-B7DE58AD-5D79-4301-936F-B789F4A842B3Q33183686-1CBB51DD-5BDF-4EAF-8232-5B1D009B0AA2Q33235601-BC59149A-68A7-4694-9027-C16D165AAADAQ33317621-A473021E-E39E-4D9B-8A13-A4963DD2F074Q33428310-82C58EA5-BA40-4F5C-8B89-C818438BB7CAQ33540291-1AEAB3E7-D4AA-4CAF-BD85-AAF8D44BABC2Q33637896-579045FB-A4F2-4898-B2C3-AC5DE86C0A4FQ33674615-C7E3EB26-BEC8-4738-B70A-E975F38498F4
P2860
Terminal differentiation of human breast cancer through PPAR gamma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Terminal differentiation of human breast cancer through PPAR gamma.
@en
Terminal differentiation of human breast cancer through PPAR gamma.
@nl
type
label
Terminal differentiation of human breast cancer through PPAR gamma.
@en
Terminal differentiation of human breast cancer through PPAR gamma.
@nl
prefLabel
Terminal differentiation of human breast cancer through PPAR gamma.
@en
Terminal differentiation of human breast cancer through PPAR gamma.
@nl
P2093
P1433
P1476
Terminal differentiation of human breast cancer through PPAR gamma.
@en
P2093
B M Spiegelman
C Fletcher
K J Martin
P Tontonoz
P304
P356
10.1016/S1097-2765(00)80047-7
P577
1998-02-01T00:00:00Z